David Basiji has been named CEO of Amnis, Cell-Based Assay News has learned. Basiji was previously Amnis' chief technology officer. He replaces former CEO Jack Ball. Further details about Ball's departure were not available.
Xenogen said last week that it has elected Kevin Hrusovsky to its board of directors. Hrusovsky will also join Xenogen's nominating and governance committee following its